首页> 外国专利> PREBIOTIC FOR TREATING DISORDERS ASSOCIATED WITH DISTURBED COMPOSITION OR FUNCTIONALITY OF THE INTESTINAL MICROBIOME

PREBIOTIC FOR TREATING DISORDERS ASSOCIATED WITH DISTURBED COMPOSITION OR FUNCTIONALITY OF THE INTESTINAL MICROBIOME

机译:治疗与肠道微生物组的干扰组成或功能相关的疾病的益生元

摘要

The invention relates to a prebiotic composition for use in a method of therapeutic or prophylactic treatment of disorders associated with disturbed composition or functionality of the intestinal microbiome in a subject, said use comprising oral administration of the prebiotic composition to the subject, wherein the composition contains at least 0.1% by weight of dry matter of RG-I polysaccharides originating from fruit, carrot, pea, chicory or sugar beet, said RG-I polysaccharides having a molecular weight in excess of 15 kDa and having a backbone consisting of galacturonic acid residues and rhamnose residues, said rhamnose residues being contained in alpha(1→4)-galacturonic-alpha(1→2)-rhamnose residues, wherein the molar ratio of galacturonic acid residues to rhamnose residues in the RG-I polysaccharidesis within the range of 20:1 to 1:1.
机译:本发明涉及一种益生元组合物,其用于治疗或预防性治疗与受试者中肠道微生物组的干扰组成或功能相关的疾病的方法,所述使用包括口服给予所述受试者的益生元组合物,其中所述组合物含有源自水果,胡萝卜,豌豆,菊苣或甜菜的RG-I多糖的干物质中的至少0.1重量%,所述RG-I多糖,其分子量超过15kDa并具有由半乳糖酸残基组成的骨架和螺旋瘤残留物,所述鼠李糖残留物含有α(1→4) - 热肺α-α(1→2)-Rhamnose残基,其中半乳糖酸残基与RG-1多糖中的rolamnose残基的摩尔比在范围内20:1至1:1。

著录项

  • 公开/公告号EP3846901A1

    专利类型

  • 公开/公告日2021-07-14

    原文格式PDF

  • 申请/专利权人 NUTRILEADS B.V.;

    申请/专利号EP20180762333

  • 发明设计人 ALBERS RUUD;TZOUMAKI MARIA;

    申请日2018-09-07

  • 分类号A61P3/10;A61P1/14;A61K31/732;A61K36;

  • 国家 EP

  • 入库时间 2024-06-14 21:47:36

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号